NEBO-176

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNEBO-176
Drug Alias Namehuman neural stem cell therapy (Neuro Bioscience/RLI)NEBO-176
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGibraltar
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRLI Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRLI LtdNeuro Bioscience
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A